Beth Hecht sold $256K of Xeris Biopharma (XERS)

Executed Nov 2, disclosed Nov 4, 2 days later.

Value, as filed

$256K

25,000 sh × $10.23

Executed

Nov 2

the trade date, as filed

Disclosed

Nov 4

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BH Beth Hecht See Remarks profile →

Beth Hecht (See Remarks) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $256K of XERS (25,000 sh × $10.23, as filed), executed Nov 2.

The name

XERS Xeris Biopharma Holdings, Inc. XERS · Healthcare · 32 filings in 24 months ticker →

Healthcare · Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chron…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Beth Hecht in XERS

XERSSALE Xeris Biopharma Holdings, Inc. $157K
16,666 sh × $9.41
Exec Oct 1
Filed Oct 2 · 4:54 PM ET XERSSALE Xeris Biopharma Holdings, Inc. $141K
16,666 sh × $8.49
Exec Sep 1
Filed Sep 1 · 6:21 PM ET XERSSALE Xeris Biopharma Holdings, Inc. $134K
16,666 sh × $8.01
Exec Aug 3
Filed Aug 4 · 5:16 PM ET XERSSALE Xeris Biopharma Holdings, Inc. $134K
16,666 sh × $8.03
Exec Jul 1
Filed Jul 2 · 4:38 PM ET XERSSALE Xeris Biopharma Holdings, Inc. $101K
16,667 sh × $6.06
Exec Jun 1
Filed Jun 2 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. $104K
16,667 sh × $6.23
Exec May 1
Filed May 1 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. $103K
16,567 sh × $6.24
Exec Mar 2
Filed Mar 4 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. $124K
16,667 sh × $7.45
Exec Feb 2
Filed Feb 2 · 5:30 PM ET